Opportunities lie in strategic investment formulation, identifying cost-effective locations for conducting trials, understanding global trial trends, and analyzing trial success rates. Insights into ...

Fans of Bob Saget are mourning his death this week. Joining the list of celebs and fans pouring out tributes to the "Full House" TV star and comedian is the Scleroderma Research Foundation (SRF).

As people learned about the death of comedian Bob Saget, many close to him suggested that a donation to research into a medical condition his sister suffered with and died from would be a fitting ...

Bob Saget was a tireless activist for the Scleroderma Research Foundation, inspired by the death of his sister, Gay Bob Saget was all about the jokes. But his family life was anything but funny. In ...

Two years before his death, Bob Saget quietly offered his support to a family whose 9-year-old daughter is suffering from Scleroderma, the same disease that took the life of his sister in 1994. Saget ...

Bob Saget's friends, family and former co-stars turned out for a cause close to the actor's heart on Wednesday night in Beverly Hills. Jimmy Kimmel, John Mayer and Jeff Ross stepped in to host "Cool ...

As Bob Saget is remembered by his friends and co-stars, one memory that stands out is his commitment to finding a cure for scleroderma, a rare disease for which Saget was the most high-profile ...

The overall benefit of blood pressure control is best achieved by a gradual reduction in pressure (10-15 mmHg per day) until the diastolic pressure reaches 85-90 mmHg. An excessive reduction in ...

The Scleroderma Research Foundation (SRF) — the country’s first and leading nonprofit investor in medical research into scleroderma — announced the lineup for its annual Cool Comedy • Hot Cuisine ...

Scleroderma is a health condition that involves thickening of the skin and may also affect internal organs. This condition can be difficult to diagnose due to the fact that several other health ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...